ERBA Diagnostics Enters Brazilian Market; Offers In Vitro Diagnostics to Hospitals, Testing Labs And Physicians Clinics

By: via Benzinga
ERBA Diagnostics, Inc. (NYSE MKT: ERB) today announced its fully integrated portfolio of in vitro diagnostics platforms and reagents for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.